Atlas Trials

A Study To Compare The Effects Of The Infusion Of A Sepsis Drug Between Healthy Adults And Adults With Damaged Livers

Clinical trial NCT00158769 · COMPLETED

Trial details

NCT number
NCT00158769
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Sepsis
Start date
2005-03-31
Primary completion
2005-10-26
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.